Infographic: What CRISPR is curing in 2020

| | June 12, 2020
dsc cr
Credit: James Steinberg
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

CRISPR-Cas9 is a method for quickly and accurately editing the genome of virtually any living thing. Using custom-built guide RNA paired with a cutting enzyme (Cas9), it can find and snip a selected sequence of DNA or RNA, eliminating or replacing a “bad” gene. Since it was first described, in late 2012, CRISPR has drastically accelerated the scope of research and moved into practical applications in medicine. So far in 2020, there are 15 trials underway. In medicine, where new drugs take a decade or more to develop, that’s game changing.

ezgif be cb b
Sources: ClinicalTrials.gov (What’s Being Treated), publicly available data as of December 2018 (Global Research)

Read the original post

Related article:  Viewpoint: We should be careful about 'crossing the germline' in gene editing humans
Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend